Early clinical development of a live, attenuated combination vaccine against Shigella and ETEC diarrhoea

Project Information

SHIGETECVAX

Grant agreement ID: 815568

DOI

10.3030/815568

EC signature date 30 April 2019

Start date 1 September 2019

End date 31 March 2026

Funded under

• SOCIETAL CHALLENGES - Health, demographic change and well-being

Total cost

No data

EU contribution

€ 8 603 989,93

Coordinated by

EUROPEAN VACCINE INITIATIVE E.V
Germany

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Deliverables

Open Research Data Pilot (1)

ORPD: Open Research Data Pilot

tbc

Documents, reports (1)

Composition of the SEAC incl. an ethics advisor

Composition of the SEAC incl an ethics advisor

Websites, patent fillings, videos etc. (1)

SHIGETECVAX web site

SHIGETECVAX web site established and launched

Publications

Peer reviewed articles (1)

Evaluation of the Safety, Tolerability and Immunogenicity of ShigETEC, an Oral Live Attenuated Shigella-ETEC Vaccine in Placebo-Controlled Randomized Phase 1 Trial

Author(s): Girardi, Petra, Shushan Harutyunyan, Irene Neuhauser, Katharina Glaninger, Orsolya Korda, Gábor Nagy, Eszter Nagy, Valéria Szijártó, Denes Pall, Krisztina Szarka, Gábor Kardos, Tamás Henics, and Frank J. Malinoski
Published in: Vaccines, 2022, ISSN 2076-393X
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/vaccines10020340